MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema.
Gregoire FM, Zhang F, Clarke HJ, Gustafson TA, Sears DD, Favelyukis S, Lenhard J, Rentzeperis D, Clemens LE, Mu Y, Lavan BE.
Mol Endocrinol. 2009 Jul;23(7):975-88. Epub 2009 Apr 23.PMID: 19389808 [PubMed - indexed for MEDLINE]Related articles